Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Philippines FDA Slashes Approval Timelines For Generic Drugs
Cuts Review From 120 To 45 Days As President Urges Lower Prices ‘Similar To India’
Feb 16 2024
•
By
David Wallace
The FDA in the Philippines is cutting approval timelines for generics • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics